{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:26:45Z","timestamp":1795159605931,"version":"4.10.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The recombinant phage endolysins AP50-31 and LysB4 were developed using genetic information from bacteriophages AP50 and B4 and were produced by microbial cultivation followed by chromatographic purification. Subsequently, appropriate formulations were developed that provided an acceptable stability of the recombinant endolysins. The bacteriolytic properties of the formulated endolysins AP50-31 and LysB4 against several bacterial strains belonging to the <jats:italic>Bacillus<\/jats:italic> genus including <jats:italic>Bacillus anthracis<\/jats:italic> (anthrax) strains were examined. AP50-31 and LysB4 displayed rapid bacteriolytic activity and broad bacteriolytic spectra within the <jats:italic>Bacillus<\/jats:italic> genus, including bacteriolytic activity against all the <jats:italic>B<\/jats:italic>. <jats:italic>anthracis<\/jats:italic> strains tested. When administered intranasally, LysB4 completely protected A\/J mice from lethality after infection with the spores of <jats:italic>B<\/jats:italic>. <jats:italic>anthracis<\/jats:italic> Sterne. When examined at 3 days post-infection, bacterial counts in the major organs (lung, liver, kidney, and spleen) were significantly lower compared with those of the control group that was not treated with endolysin. In addition, histopathological examinations revealed a marked improvement of pathological features in the LysB4-treated group. The results of this study support the idea that phage endolysins are promising candidates for developing therapeutics against anthrax infection.<\/jats:p>","DOI":"10.1038\/s41598-017-18535-z","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T12:21:09Z","timestamp":1514895669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis"],"prefix":"10.1038","volume":"8","author":[{"given":"Sangjin","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Youn","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Mo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Soo","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Tae","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Jun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-3091","authenticated-orcid":false,"given":"Sang Yup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyeon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"18535_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cimid.2012.02.005","volume":"35","author":"M Ortatatli","year":"2012","unstructured":"Ortatatli, M. et al. Antimicrobial susceptibility and molecular subtyping of 55 Turkish Bacillus anthracis strains using 25-loci multiple-locus VNTR analysis. Comp Immunol Microbiol Infect Dis 35, 355\u2013361 (2012).","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"18535_CR2","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1128\/AAC.46.12.3843-3845.2002","volume":"46","author":"PR Coker","year":"2002","unstructured":"Coker, P. R., Smith, K. L. & Hugh-Jones, M. E. Antimicrobial susceptibilities of diverse Bacillus anthracis isolates. Antimicrob Agents Chemother 46, 3843\u20133845 (2002).","journal-title":"Antimicrob Agents Chemother"},{"key":"18535_CR3","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1128\/AAC.44.6.1766-1766.2000","volume":"44","author":"CH Choe","year":"2000","unstructured":"Choe, C. H., Bouhaouala, S. S., Brook, I., Elliot, T. B. & Knudson, G. B. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob Agents Chemother 44, 1766 (2000).","journal-title":"Antimicrob Agents Chemother"},{"key":"18535_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0924-8579(01)00464-2","volume":"18","author":"I Brook","year":"2001","unstructured":"Brook, I. et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents 18, 559\u2013562 (2001).","journal-title":"Int J Antimicrob Agents"},{"key":"18535_CR5","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1128\/AAC.47.7.2362-2365.2003","volume":"47","author":"LB Price","year":"2003","unstructured":"Price, L. B. et al. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother 47, 2362\u20132365 (2003).","journal-title":"Antimicrob Agents Chemother"},{"key":"18535_CR6","unstructured":"Alibek, K. & Handelman, S. Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it (1st ed.) (Random House New York. 1999)."},{"key":"18535_CR7","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","volume":"287","author":"TV Inglesby","year":"2002","unstructured":"Inglesby, T. V. et al. Anthrax as a biological weapon, 2002: updated recommendations for management. Jama 287, 2236\u20132252 (2002).","journal-title":"Jama"},{"key":"18535_CR8","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1021\/jm901024b","volume":"53","author":"DG Bouzianas","year":"2010","unstructured":"Bouzianas, D. G. Current and future medical approaches to combat the anthrax threat. J Med Chem 53, 4305\u20134331 (2010).","journal-title":"J Med Chem"},{"key":"18535_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1126\/science.294.5543.759","volume":"294","author":"M Enserink","year":"2001","unstructured":"Enserink, M. Bioterrorism. Researchers question obsession with Cipro. Science 294, 759\u2013761 (2001).","journal-title":"Science"},{"key":"18535_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/hs.2015.0032","volume":"13","author":"E Huang","year":"2015","unstructured":"Huang, E. et al. Antitoxin treatment of inhalation anthrax: a systematic review. Health Secur 13, 365\u2013377 (2015).","journal-title":"Health Secur"},{"key":"18535_CR11","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature01026","volume":"418","author":"R Schuch","year":"2002","unstructured":"Schuch, R., Nelson, D. & Fischetti, V. A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884\u2013889 (2002).","journal-title":"Nature"},{"key":"18535_CR12","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1128\/JB.188.7.2711-2714.2006","volume":"188","author":"P Yoong","year":"2006","unstructured":"Yoong, P., Schuch, R., Nelson, D. & Fischetti, V. A. PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 188, 2711\u20132714 (2006).","journal-title":"J Bacteriol"},{"key":"18535_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mib.2005.06.002","volume":"8","author":"MJ Loessner","year":"2005","unstructured":"Loessner, M. J. Bacteriophage endolysins-current state of research and applications. Curr Opin Microbiol 8, 480\u2013487 (2005).","journal-title":"Curr Opin Microbiol"},{"key":"18535_CR14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/aem.61.3.1150-1152.1995","volume":"61","author":"MJ Loessner","year":"1995","unstructured":"Loessner, M. J., Schneider, A. & Scherer, S. A new procedure for efficient recovery of DNA, RNA, and proteins from Listeria cells by rapid lysis with a recombinant bacteriophage endolysin. Appl Environ Microbiol 61, 1150\u20131152 (1995).","journal-title":"Appl Environ Microbiol"},{"key":"18535_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","volume":"300","author":"VA Fischetti","year":"2010","unstructured":"Fischetti, V. A. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol 300, 357\u2013362 (2010).","journal-title":"Int J Med Microbiol"},{"key":"18535_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/jac\/dkg485","volume":"52","author":"I Jado","year":"2003","unstructured":"Jado, I. et al. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52, 967\u2013973 (2003).","journal-title":"J Antimicrob Chemother"},{"key":"18535_CR17","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","volume":"187","author":"S O\u2019Flaherty","year":"2005","unstructured":"O\u2019Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G. F. & Ross, R. P. The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187, 7161\u20137164 (2005).","journal-title":"J Bacteriol"},{"key":"18535_CR18","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1128\/JB.00686-08","volume":"190","author":"MJ Mayer","year":"2008","unstructured":"Mayer, M. J., Narbad, A. & Gasson, M. J. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J Bacteriol 190, 6734\u20136740 (2008).","journal-title":"J Bacteriol"},{"key":"18535_CR19","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1128\/AAC.49.11.4789-4792.2005","volume":"49","author":"JM Entenza","year":"2005","unstructured":"Entenza, J. M., Loeffler, J. M., Grandgirard, D., Fischetti, V. A. & Moreillon, P. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother 49, 4789\u20134792 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"18535_CR20","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1073\/pnas.061038398","volume":"98","author":"D Nelson","year":"2001","unstructured":"Nelson, D., Loomis, L. & Fischetti, V. A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98, 4107\u20134112 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"18535_CR21","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","volume":"71","author":"JM Loeffler","year":"2003","unstructured":"Loeffler, J. M., Djurkovic, S. & Fischetti, V. A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71, 6199\u20136204 (2003).","journal-title":"Infect Immun"},{"key":"18535_CR22","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1371\/journal.ppat.0030028","volume":"3","author":"JA McCullers","year":"2007","unstructured":"McCullers, J. A., Karlstrom, A., Iverson, A. R., Loeffler, J. M. & Fischetti, V. A. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 3, e28 (2007).","journal-title":"PLoS Pathog"},{"key":"18535_CR23","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1126\/science.1066869","volume":"294","author":"JM Loeffler","year":"2001","unstructured":"Loeffler, J. M., Nelson, D. & Fischetti, V. A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170\u20132172 (2001).","journal-title":"Science"},{"key":"18535_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/AAC.49.1.111-117.2005","volume":"49","author":"Q Cheng","year":"2005","unstructured":"Cheng, Q., Nelson, D., Zhu, S. & Fischetti, V. A. Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 49, 111\u2013117 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"18535_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/521305","volume":"196","author":"M Rashel","year":"2007","unstructured":"Rashel, M. et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196, 1237\u20131247 (2007).","journal-title":"J Infect Dis"},{"key":"18535_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/bbug.1.1.9818","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton, M., Ross, P., McAuliffe, O., O\u2019Mahony, J. & Coffey, A. Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 1, 9\u201316 (2010).","journal-title":"Bioeng Bugs"},{"key":"18535_CR27","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1128\/AEM.01124-08","volume":"74","author":"S Sozhamannan","year":"2008","unstructured":"Sozhamannan, S. et al. Molecular characterization of a variant of Bacillus anthracis-specific phage AP50 with improved bacteriolytic activity. Appl Environ Microbiol 74, 6792\u20136796 (2008).","journal-title":"Appl Environ Microbiol"},{"key":"18535_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2180-12-33","volume":"12","author":"B Son","year":"2012","unstructured":"Son, B. et al. Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4. BMC Microbiol 12, 33 (2012).","journal-title":"BMC Microbiol"},{"key":"18535_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00705-013-1719-2","volume":"158","author":"JH Lee","year":"2013","unstructured":"Lee, J. H., Shin, H., Son, B., Heu, S. & Ryu, S. Characterization and complete genome sequence of a virulent bacteriophage B4 infecting food-borne pathogenic Bacillus cereus. Arch Virol 158, 2101\u20132108 (2013).","journal-title":"Arch Virol"},{"key":"18535_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nmeth.1701","volume":"8","author":"TN Petersen","year":"2011","unstructured":"Petersen, T. N., Brunak, S., von Heijne, G. & Nielsen, H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8, 785\u2013786 (2011).","journal-title":"Nat Methods"},{"key":"18535_CR31","first-page":"175","volume":"6","author":"EL Sonnhammer","year":"1998","unstructured":"Sonnhammer, E. L., von Heijne, G. & Krogh, A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol 6, 175\u2013182 (1998).","journal-title":"Proc Int Conf Intell Syst Mol Biol"},{"key":"18535_CR32","doi-asserted-by":"publisher","first-page":"e00863","DOI":"10.1128\/genomeA.00863-13","volume":"1","author":"JW Maroun","year":"2013","unstructured":"Maroun, J. W., Whitcher, K. J., Chamakura, K. R. & Kuty Everett, G. F. Complete genome of Bacillus thuringiensis myophage spock. Genome Announc 1, e00863\u201313 (2013).","journal-title":"Genome Announc"},{"key":"18535_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.virol.2015.12.012","volume":"489","author":"AB Sauder","year":"2016","unstructured":"Sauder, A. B. et al. Genomic characterization and comparison of seven Myoviridae bacteriophage infecting Bacillus thuringiensis. Virology 489, 243\u2013251 (2016).","journal-title":"Virology"},{"key":"18535_CR34","first-page":"e01199","volume":"3","author":"I Erill","year":"2015","unstructured":"Erill, I. & Caruso, S. M. Genome sequences of two Bacillus cereus group bacteriophages, Eyuki and AvesoBmore. Genome Announc 3, e01199\u201315 (2015).","journal-title":"Genome Announc"},{"key":"18535_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","volume":"55","author":"M Mock","year":"2001","unstructured":"Mock, M. & Fouet, A. Anthrax. Annu Rev Microbiol 55, 647\u2013671 (2001).","journal-title":"Annu Rev Microbiol"},{"key":"18535_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton, M. et al. The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice. Bioeng Bugs 1, 404\u2013407 (2010).","journal-title":"Bioeng Bugs"},{"key":"18535_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12998\/wjcc.v3.i1.20","volume":"3","author":"AK Goel","year":"2015","unstructured":"Goel, A. K. Anthrax: A disease of biowarfare and public health importance. World J Clin Cases 3, 20\u201333 (2015).","journal-title":"World J Clin Cases"},{"key":"18535_CR38","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1128\/IAI.72.8.4801-4809.2004","volume":"72","author":"CR Lyons","year":"2004","unstructured":"Lyons, C. R. et al. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infection and immunity 72, 4801\u20134809 (2004).","journal-title":"Infection and immunity"},{"key":"18535_CR39","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/IAI.01875-06","volume":"75","author":"CL Loving","year":"2007","unstructured":"Loving, C. L., Kennett, M., Lee, G. M., Grippe, V. K. & Merkel, T. J. Murine aerosol challenge model of anthrax. Infection and immunity 75, 2689\u20132698 (2007).","journal-title":"Infection and immunity"},{"key":"18535_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/IAI.00633-08","volume":"77","author":"CL Loving","year":"2009","unstructured":"Loving, C. L. et al. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infection and immunity 77, 255\u2013265 (2009).","journal-title":"Infection and immunity"},{"key":"18535_CR41","doi-asserted-by":"crossref","first-page":"TBS-0001","DOI":"10.1128\/microbiolspec.TBS-0001-2012","volume":"3","author":"S Welkos","year":"2015","unstructured":"Welkos, S., Bozue, J., Twenhafel, N. & Cote, C. Animal models for the pathogenesis, treatment, and prevention of infection by Bacillus anthracis. Microbiol Spectr 3, TBS-0001\u20132012 (2015).","journal-title":"Microbiol Spectr"},{"key":"18535_CR42","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/IAI.01875-06","volume":"75","author":"CL Loving","year":"2007","unstructured":"Loving, C. L., Kennett, M., Lee, G. M., Grippe, V. K. & Merkel, T. J. Murine aerosol challenge model of anthrax. Infect Immun 75, 2689\u20132698 (2007).","journal-title":"Infect Immun"},{"key":"18535_CR43","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1128\/AEM.66.6.2627-2630.2000","volume":"66","author":"E Helgason","year":"2000","unstructured":"Helgason, E. et al. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl Environ Microbiol 66, 2627\u20132630 (2000).","journal-title":"Appl Environ Microbiol"},{"key":"18535_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.forsciint.2015.10.003","volume":"257","author":"Y Fujinami","year":"2015","unstructured":"Fujinami, Y., Hosokawa-Muto, J. & Mizuno, N. Evaluation of tools for environmental sampling of Bacillus anthracis spores. Forensic Sci Int 257, 376\u2013378 (2015).","journal-title":"Forensic Sci Int"},{"key":"18535_CR45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s11274-013-1576-x","volume":"30","author":"JA Tufts","year":"2014","unstructured":"Tufts, J. A., Calfee, M. W., Lee, S. D. & Ryan, S. P. Bacillus thuringiensis as a surrogate for Bacillus anthracis in aerosol research. World J Microbiol Biotechnol 30, 1453\u20131461 (2014).","journal-title":"World J Microbiol Biotechnol"},{"key":"18535_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijantimicag.2012.10.011","volume":"41","author":"SY Jun","year":"2013","unstructured":"Jun, S. Y. et al. Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1. Int J Antimicrob Agents 41, 156\u2013161 (2013).","journal-title":"Int J Antimicrob Agents"},{"key":"18535_CR47","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948 (2007).","journal-title":"Bioinformatics"},{"key":"18535_CR48","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1128\/IAI.00205-11","volume":"79","author":"MK Wilson","year":"2011","unstructured":"Wilson, M. K. et al. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice. Infect Immun 79, 3012\u20133019 (2011).","journal-title":"Infect Immun"},{"key":"18535_CR49","first-page":"e00769","volume":"2","author":"SK Kim","year":"2014","unstructured":"Kim, S. K. et al. Complete genome sequence of Bacillus anthracis HYU01, isolated from soil samples in the Korean peninsula. Genome Announc 2, e00769\u201314 (2014).","journal-title":"Genome Announc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18535-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:57:01Z","timestamp":1671847021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["18535"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18535-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,8]]},"assertion":[{"value":"12 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18"}}